Next-Generation Sequencing (NGS) Services Market Size, Growth Trends, Top Players, Application Potential and Forecast to 2031

QY Research has recently published a report, titled "Next-Generation Sequencing (NGS) Services Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". The global Next-Generation Sequencing (NGS) Services market is comprehensively analyzed in the report with the main objective of providing accurate market data and useful recommendations to help players to gain strong growth in future. The report is compiled by subject matter experts and experienced market analysts, which makes it highly authentic and reliable. Readers are provided with deep analysis of historical and future market scenarios to get sound understanding of market competition and other important aspects. The report offers exhaustive research on market dynamics, key segments, leading players, and different regional markets. It is a complete package of thorough analysis and research on the global Next-Generation Sequencing (NGS) Services market.

The global market for Next-Generation Sequencing (NGS) Services was estimated to be worth US$ 21241 million in 2024 and is forecast to a readjusted size of US$ 65046 million by 2031 with a CAGR of 16.4% during the forecast period 2025-2031.

Get PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.in/request-sample/pharma-healthcare-next-generation-sequencing-ngs-services-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

The accelerated implementation of global precision medicine strategies and continuous advancements in bioinformatics are creating vast growth opportunities for the NGS services market. Increased government funding for genomics research and clinical translation projects such as early cancer screening is driving demand expansion among hospitals, research institutions, and biopharmaceutical companies. With significant reductions in sequencing costs and faster turnaround times, NGS has transitioned from exploratory research to large-scale clinical applications, covering areas such as tumor profiling, companion diagnostics, pathogen detection, and rare disease screening. Across the value chain, deeper collaborations between platform technology providers, service operators, and downstream application sectors are accelerating the adoption of new service models and value-added applications.

Despite rapid growth, the NGS services market faces challenges such as the lack of standardized data interpretation protocols, stringent regulatory requirements for clinical applications, and compliance risks related to data security. Regulatory differences across countries and regions increase the complexity of cross-border operations. High-quality bioinformatics analysis depends on experienced technical teams and robust computing infrastructure, creating barriers to entry. Certain niche segments demand extremely high sequencing accuracy and sensitivity, requiring continuous investment in R&D and quality control. Additionally, as market competition intensifies, balancing price pressures with differentiated service capabilities has become a critical test for business sustainability and expansion.

In the coming years, downstream demand for NGS services will diversify and integrate across multiple sectors. In healthcare, personalized treatment and early disease screening will continue to expand, particularly in the precision diagnosis of cancer, infectious diseases, and genetic disorders. In the biopharmaceutical industry, NGS will play a key role in new drug target discovery, elucidating drug response mechanisms, and stratifying patients in clinical trials. Agriculture and environmental sciences will further leverage NGS for crop improvement, animal breeding, and microbiome monitoring. Meanwhile, AI-driven automated analysis and cloud-based data collaboration will drive NGS services toward higher efficiency and broader accessibility, meeting the growing need for real-time, large-scale, multidimensional genetic information in both research and industrial applications.

The competitive landscape of the global Next-Generation Sequencing (NGS) Services market is broadly studied in the report with large focus on recent developments, future plans of top players, and key growth strategies adopted by them. The analysts authoring the report have profiled almost every major player of the global Next-Generation Sequencing (NGS) Services market and thrown light on their crucial business aspects such as production, areas of operation, and product portfolio. All companies analyzed in the report are studied on the basis of vital factors such as market share, market growth, company size, production volume, revenue, and earnings.

Key Players Mentioned in the Global Next-Generation Sequencing (NGS) Services Market Research Report:

Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Thermo Fisher Scientific
Macrogen
Oxford Nanopore
Novogene
Pacific Biosciences
Azenta Life Sciences

The report offers great insights into important segments of the global Next-Generation Sequencing (NGS) Services market while concentrating on their CAGR, market size, market share, and future growth potential. The global Next-Generation Sequencing (NGS) Services market is mainly segmented according to type of product, application, and region. Each segment in these categories is extensively researched to become familiar with their growth prospects and key trends. Segmental analysis is highly important to identify key growth pockets of a global market. The report provides specific information on the market growth and demand of different products and applications to help players to focus on profitable areas of the global Next-Generation Sequencing (NGS) Services market.

Details of Next-Generation Sequencing (NGS) Services Market Segmentation: -

Segment by Type:

Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing

Segment by Application:

Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others

Research Methodology

This report has been compiled using latest primary and secondary research methodologies such as data triangulation, qualitative and quantitative analysis, and top-down and bottom-up approaches. The researchers also referred to reliable secondary sources for collecting important data and statistics. All the findings of the research study have been verified and revalidated with the help of authentic primary sources.

The researchers create a unique model and customize it for each research study. Their market forecasts are based on the industry-best combination of domain expertise, industry knowledge and experience, technological analysis, and economic tools. Technological market models are generally adopted for long-term market forecasting, whereas econometric models are adopted for short-term forecasting. The researchers were provided with advanced analysis tools at the time of the preparation of the report.

Report Objectives

(1) To carefully analyze and estimate the size of the global Next-Generation Sequencing (NGS) Services market

(2) To clearly segment the global Next-Generation Sequencing (NGS) Services market and estimate the market size of the segments

(3) To provide details about key strategies adopted by leading players of the global Next-Generation Sequencing (NGS) Services market

(4) To help readers understand current and future market scenarios

(5) To provide information about latest trends of the global Next-Generation Sequencing (NGS) Services market and its key segments

(6) To assess the contribution of each region or country to the global Next-Generation Sequencing (NGS) Services market

(7) To provide information on important drivers, restraints, and opportunities of the global Next-Generation Sequencing (NGS) Services market

(8) To accurately calculate the market shares of key segments, regions, and companies in the global Next-Generation Sequencing (NGS) Services market

Request Pre-Order Enquiry or Customized Research on This Report: https://www.qyresearch.in/pre-order-inquiry/pharma-healthcare-next-generation-sequencing-ngs-services-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Table of Content

1 Market Overview
1.1 Next-Generation Sequencing (NGS) Services Product Introduction
1.2 Global Next-Generation Sequencing (NGS) Services Market Size Forecast (2020-2031)
1.3 Next-Generation Sequencing (NGS) Services Market Trends & Drivers
1.3.1 Next-Generation Sequencing (NGS) Services Industry Trends
1.3.2 Next-Generation Sequencing (NGS) Services Market Drivers & Opportunity
1.3.3 Next-Generation Sequencing (NGS) Services Market Challenges
1.3.4 Next-Generation Sequencing (NGS) Services Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Competitive Analysis by Company
2.1 Global Next-Generation Sequencing (NGS) Services Players Revenue Ranking (2024)
2.2 Global Next-Generation Sequencing (NGS) Services Revenue by Company (2020-2025)
2.3 Key Companies Next-Generation Sequencing (NGS) Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Next-Generation Sequencing (NGS) Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Next-Generation Sequencing (NGS) Services
2.6 Next-Generation Sequencing (NGS) Services Market Competitive Analysis
2.6.1 Next-Generation Sequencing (NGS) Services Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Next-Generation Sequencing (NGS) Services Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Sequencing (NGS) Services as of 2024)
2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Targeted Sequencing
3.1.2 Whole Exome Sequencing
3.1.3 Whole Genome Sequencing
3.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Type
3.2.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Next-Generation Sequencing (NGS) Services Sales Value, by Type (2020-2031)
3.2.3 Global Next-Generation Sequencing (NGS) Services Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Biopharma Companies
4.1.3 Academic & Research Organizations
4.1.4 Others
4.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Application
4.2.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Next-Generation Sequencing (NGS) Services Sales Value, by Application (2020-2031)
4.2.3 Global Next-Generation Sequencing (NGS) Services Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region
5.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Region
5.1.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2020-2025)
5.1.3 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2026-2031)
5.1.4 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
5.2.2 North America Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
5.3.2 Europe Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
5.4.2 Asia Pacific Next-Generation Sequencing (NGS) Services Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
5.5.2 South America Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
5.6.2 Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Next-Generation Sequencing (NGS) Services Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
6.3 United States
6.3.1 United States Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
6.3.2 United States Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
6.4.2 Europe Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
6.5.2 China Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
6.5.3 China Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
6.6.2 Japan Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
6.7.2 South Korea Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
6.8.2 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
6.9.2 India Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
6.9.3 India Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031

7 Company Profiles
7.1 Eurofins Scientific
7.1.1 Eurofins Scientific Profile
7.1.2 Eurofins Scientific Main Business
7.1.3 Eurofins Scientific Next-Generation Sequencing (NGS) Services Products, Services and Solutions
7.1.4 Eurofins Scientific Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
7.1.5 Eurofins Scientific Recent Developments
7.2 Natera
7.2.1 Natera Profile
7.2.2 Natera Main Business
7.2.3 Natera Next-Generation Sequencing (NGS) Services Products, Services and Solutions
7.2.4 Natera Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
7.2.5 Natera Recent Developments
7.3 BGI
7.3.1 BGI Profile
7.3.2 BGI Main Business
7.3.3 BGI Next-Generation Sequencing (NGS) Services Products, Services and Solutions
7.3.4 BGI Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
7.3.5 BGI Recent Developments
7.4 Illumina
7.4.1 Illumina Profile
7.4.2 Illumina Main Business
7.4.3 Illumina Next-Generation Sequencing (NGS) Services Products, Services and Solutions
7.4.4 Illumina Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
7.4.5 Illumina Recent Developments
7.5 Roche
7.5.1 Roche Profile
7.5.2 Roche Main Business
7.5.3 Roche Next-Generation Sequencing (NGS) Services Products, Services and Solutions
7.5.4 Roche Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
7.5.5 Roche Recent Developments
7.6 LabCorp
7.6.1 LabCorp Profile
7.6.2 LabCorp Main Business
7.6.3 LabCorp Next-Generation Sequencing (NGS) Services Products, Services and Solutions
7.6.4 LabCorp Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
7.6.5 LabCorp Recent Developments
7.7 Berry Genomics
7.7.1 Berry Genomics Profile
7.7.2 Berry Genomics Main Business
7.7.3 Berry Genomics Next-Generation Sequencing (NGS) Services Products, Services and Solutions
7.7.4 Berry Genomics Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
7.7.5 Berry Genomics Recent Developments
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Profile
7.8.2 Thermo Fisher Scientific Main Business
7.8.3 Thermo Fisher Scientific Next-Generation Sequencing (NGS) Services Products, Services and Solutions
7.8.4 Thermo Fisher Scientific Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
7.8.5 Thermo Fisher Scientific Recent Developments
7.9 Macrogen
7.9.1 Macrogen Profile
7.9.2 Macrogen Main Business
7.9.3 Macrogen Next-Generation Sequencing (NGS) Services Products, Services and Solutions
7.9.4 Macrogen Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
7.9.5 Macrogen Recent Developments
7.10 Oxford Nanopore
7.10.1 Oxford Nanopore Profile
7.10.2 Oxford Nanopore Main Business
7.10.3 Oxford Nanopore Next-Generation Sequencing (NGS) Services Products, Services and Solutions
7.10.4 Oxford Nanopore Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
7.10.5 Oxford Nanopore Recent Developments
7.11 Novogene
7.11.1 Novogene Profile
7.11.2 Novogene Main Business
7.11.3 Novogene Next-Generation Sequencing (NGS) Services Products, Services and Solutions
7.11.4 Novogene Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
7.11.5 Novogene Recent Developments
7.12 Pacific Biosciences
7.12.1 Pacific Biosciences Profile
7.12.2 Pacific Biosciences Main Business
7.12.3 Pacific Biosciences Next-Generation Sequencing (NGS) Services Products, Services and Solutions
7.12.4 Pacific Biosciences Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
7.12.5 Pacific Biosciences Recent Developments
7.13 Azenta Life Sciences
7.13.1 Azenta Life Sciences Profile
7.13.2 Azenta Life Sciences Main Business
7.13.3 Azenta Life Sciences Next-Generation Sequencing (NGS) Services Products, Services and Solutions
7.13.4 Azenta Life Sciences Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
7.13.5 Azenta Life Sciences Recent Developments

8 Industry Chain Analysis
8.1 Next-Generation Sequencing (NGS) Services Industrial Chain
8.2 Next-Generation Sequencing (NGS) Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Next-Generation Sequencing (NGS) Services Sales Model
8.5.2 Sales Channel
8.5.3 Next-Generation Sequencing (NGS) Services Distributors

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

Contact US

Ankit Jain - Director, Global Digital Marketing

QY Research, INC.
India Office -
315Work Avenue, Raheja Woods, Kalyani Nagar,
Pune, Maharashtra 411006, India
Web - https://www.qyresearch.in
Email- ankit@qyresearch.com

About US:

QYResearch is a leading global market research and consulting company established in 2007. With over 17 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability.

This release was published on openPR.